Early dissemination seeds metastasis in breast cancer

Nature

Volumn 540, Issue 7634, 2016, Pages 552-558

  Hosseini, Hedayatollah ^a   Obradovic, Milan M S ^a,h   Hoffmann, Martin ^b   Harper, Kathryn L ^c   Sosa, Maria Soledad ^c   Werner Klein, Melanie ^a   Nanduri, Lahiri Kanth ^a,i   Werno, Christian ^b   Ehrl, Carolin ^a   Maneck, Matthias ^a   Patwary, Nina ^a   Haunschild, Gundula ^a   Guzvic, Miodrag ^a   Reimelt, Christian ^a   Grauvogl, Michael ^a   Eichner, Norbert ^a   Weber, Florian ^a   Hartkopf, Andreas D ^d   Taran, Florin Andrei ^d   Brucker, Sara Y ^d   Fehm, Tanja ^e   Rack, Brigitte ^f   Buchholz, Stefan ^g   Spang, Rainer ^a   Meister, Gunter ^a   Aguirre Ghiso, Julio A ^c   Klein, Christoph A ^a,b   more..

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Project Group Personalized Tumour Therapy Fraunhofer Institute of Experimental Medicine and Toxicology   (Germany)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

CANCER; CELLS AND CELL COMPONENTS; GENE EXPRESSION; PHENOTYPE; RODENT; TUMOR;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CELL DENSITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; METASTASIS; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 85010855064     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature20785     Document Type: Article

References (55)

1. Aguirre-Ghiso, J. A., Bragado, P., Sosa, M. S. Metastasis awakening: Targeting dormant cancer. Nat. Med. 19, 276-277 (2013).
2. Polzer, B., Klein, C. A. Metastasis awakening: The challenges of targeting minimal residual cancer. Nat. Med. 19, 274-275 (2013).
3. Cole, B. F., Gelber, R. D., Gelber, S., Coates, A. S., Goldhirsch, A. Polychemotherapy for early breast cancer: An overview of the randomised clinical trials with quality-adjusted survival analysis. Lancet 358, 277-286 (2001).
4. Gianni, L., et al. Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: A 4-year follow-up of a randomised controlled trial. Lancet Oncol. 12, 236-244 (2011).
5. Klein, C. A., et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360, 683-689 (2002).
6. Schmidt-Kittler, O., et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc. Natl Acad. Sci. USA 100, 7737-7742 (2003).
7. Klein, C. A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 9, 302-312 (2009).
8. Hüsemann, Y., et al. Systemic spread is an early step in breast cancer. Cancer Cell 13, 58-68 (2008).
9. Rhim, A. D., et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349-361 (2012).
10. Eyles, J., et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J. Clin. Invest. 120, 2030-2039 (2010).
11. Banys, M., et al. Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast. Breast Cancer Res. Treat. 131, 801-808 (2012).
12. Sänger, N., et al. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ. Int. J. Cancer 129, 2522-2526 (2011).
13. Valastyan, S., Weinberg, R. A. Tumor metastasis: Molecular insights and evolving paradigms. Cell 147, 275-292 (2011).
14. Fernandez-Valdivia, R., et al. Revealing progesterone's role in uterine and mammary gland biology: Insights from the mouse. Semin. Reprod. Med. 23, 22-37 (2005).
15. Mulac-Jericevic, B., Lydon, J. P., DeMayo, F. J., Conneely, O. M. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl Acad. Sci. USA 100, 9744-9749 (2003).
16. Aupperlee, M. D., Smith, K. T., Kariagina, A., Haslam, S. Z. Progesterone receptor isoforms A and B: Temporal and spatial differences in expression during murine mammary gland development. Endocrinology 146, 3577-3588 (2005).
17. Brisken, C. Progesterone signalling in breast cancer: A neglected hormone coming into the limelight. Nat. Rev. Cancer 13, 385-396 (2013).
18. Liao, M. J., et al. Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. Cancer Res. 67, 8131-8138 (2007).
19. Korkaya, H., Paulson, A., Iovino, F., Wicha, M. S. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 27, 6120-6130 (2008).
20. Ginestier, C., et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567 (2007).
21. Lee, Y. J., Gorski, J. Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy. Proc. Natl Acad. Sci. USA 93, 15180-15184 (1996).
22. Stephens, P. J., et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 486, 400-404 (2012).
23. Fehm, T., et al. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer 107, 885-892 (2006).
24. Gužvić, M., et al. Combined genome and transcriptome analysis of single disseminated cancer cells from bone marrow of prostate cancer patients reveals unexpected transcriptomes. Cancer Res. 74, 7383-7394 (2014).
25. Klein, C. A. Framework models of tumor dormancy from patient-derived observations. Curr. Opin. Genet. Dev. 21, 42-49 (2011).
26. Brastianos, P. K., et al. Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov. 5, 1164-1177 (2015).
27. Brisken, C., et al. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 14, 650-654 (2000).
28. Fernandez-Valdivia, R., et al. The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. Dev. Biol. 328, 127-139 (2009).
29. Asselin-Labat, M. L., et al. Steroid hormone receptor status of mouse mammary stem cells. J. Natl. Cancer Inst. 98, 1011-1014 (2006).
30. Joshi, P. A., et al. Progesterone induces adult mammary stem cell expansion. Nature 465, 803-807 (2010).
31. Mukherjee, A., et al. Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. FASEB J. 24, 4408-4419 (2010).
32. Narod, S. A., Iqbal, J., Giannakeas, V., Sopik, V., Sun, P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol. 1, 888-896 (2015).
33. Astolfi, A., et al. Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary arcinoma. Am. J. Pathol. 166, 1205-1216 (2005).
34. Ignatiadis, M., et al. HER2-positive circulating tumor cells in breast cancer. PLoS One 6, e15624 (2011).
35. Hafner, C., et al. Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc. Natl Acad. Sci. USA 104, 13450-13454 (2007).
36. Hafner, C., et al. Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proc. Natl Acad. Sci. USA 107, 20780-20785 (2010).
37. Pollock, P. M., et al. High frequency of BRAF mutations in nevi. Nat. Genet. 33, 19-20 (2003).
38. Hutchinson, J. N., Jin, J., Cardiff, R. D., Woodgett, J. R., Muller, W. J. Activation of Akt-1 (PKB-) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res. 64, 3171-3178 (2004).
39. Liu, H., et al. MYC suppresses cancer metastasis by direct transcriptional silencing of V and 3 integrin subunits. Nat. Cell Biol. 14, 567-574 (2012).
40. VerMilyea, M. D., et al. Transcriptome asymmetry within mouse zygotes but not between early embryonic sister blastomeres. EMBO J. 30, 1841-1851 (2011).
41. Dull, T., et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471 (1998).
42. Petti, L. M., Ray, F. A. Transformation of mortal human fibroblasts and activation of a growth inhibitory pathway by the bovine papillomavirus E5 oncoprotein. Cell Growth Differ. 11, 395-408 (2000).
43. Stewart, S. A., et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9, 493-501 (2003).
44. Thery, C., Amigorena, S., Raposo, G., Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current Protoc. Cell Biology Chapter 3, Unit 3.22 (2006).
45. Dueck, A., Eichner, A., Sixt, M., Meister, G. A miR-155-dependent microRNA hierarchy in dendritic cell maturation and macrophage activation. FEBS Lett. 588, 632-640 (2014).
46. Meyer, L. R., et al. The UCSC genome browser database: Extensions and updates 2013. Nucleic Acids Res. 41, D64-D69 (2013).
47. Yang, Y. H., Buckley, M. J., Speed, T. P. Analysis of cDNA microarray images. Brief. Bioinform. 2, 341-349 (2001).
48. Yang, Y. H., et al. Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, e15 (2002).
49. Khojasteh, M., Lam, W. L., Ward, R. K., MacAulay, C. A stepwise framework for the normalization of array CGH data. BMC Bioinformatics 6, 274 (2005).
50. Smyth, G. K., Speed, T. Normalization of cDNA microarray data. Methods 31, 265-273 (2003).
51. Ritchie, M. E., et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
52. Marioni, J. C., et al. Breaking the waves: Improved detection of copy number variation from microarray-based comparative genomic hybridization. Genome Biol. 8, R228 (2007).
53. Venkatraman, E. S., Olshen, A. B. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 23, 657-663 (2007).
54. Mermel, C. H., et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).
55. Klein, C. A., et al. Comparative genomic hybridization, loss of heterozygosity, DNA sequence analysis of single cells. Proc. Natl Acad. Sci. USA 96, 4494-4499 (1999).